| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.9 |
| mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
PF-4708671 |
GDSC1000 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |